Neotropix

Neotropix

Lung Cancer Treatments | Neuroblastoma | Small Cell Lung Cancer Treatment. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD8—11m (Dealroom.co estimates May 2009.)
Malvern Iowa (HQ)
  • Edit
DateInvestorsAmountRound

$10.0m

Series A
N/A

$1.4m

Early VC
Total FundingCAD15.5m

Recent News about Neotropix

Edit
More about Neotropixinfo icon
Edit

Neotropix operates in the health and wellness sector, focusing on the development and research of cannabidiol (CBD) products. The company targets individuals seeking natural remedies for anxiety, neural regeneration, and cancer treatment support. Neotropix's business model revolves around the extraction and formulation of CBD compounds from marijuana plants, which are then marketed and sold to consumers. Revenue is generated through direct sales of CBD products and potentially through partnerships with medical research institutions. The company leverages scientific research to validate the efficacy of its products, aiming to provide reliable and effective health solutions. Neotropix serves a growing market of health-conscious consumers looking for alternative treatments to traditional pharmaceuticals. The company’s commitment to research and innovation positions it as a key player in the evolving CBD industry.

Keywords: CBD, neural regeneration, anxiety relief, cancer treatment, natural remedies, health and wellness, cannabidiol, marijuana extraction, scientific research, alternative treatments.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.